Observational study reveals peripheral blood MCEMP1 gene expression predicts stroke diagnosis and 1-month outcomes in stroke patients, suggesting its utility as a clinical biomarker.
This study demonstrates that peripheral blood expression of MCEMP1 may have utility for stroke diagnosis and as a prognostic biomarker of stroke outcome at 1-month.
No takes yet. Share an insight, caveat, or question.
Raman et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: